Orphan G protein-coupled receptors: from DNA to drug targets
- PMID: 12825450
Orphan G protein-coupled receptors: from DNA to drug targets
Abstract
Although G protein-coupled receptors (GPCRs) are the most numerous therapeutic targets to date, ligands remain unknown for approximately two-thirds of these receptors. The challenge in the post-genomic era is to evaluate the role of these 'orphan' GPCRs in normal physiology and disease, and to develop new therapeutics based on this information. A prevalent strategy to determine the function of these orphan GPCRs is to identify specific ligands that conditionally modulate their function. These ligands can then be used to explore the role of the receptor-ligand pair in relevant models of disease. Some promise is emerging from this infant field of functional genomics as several recently deorphanized GPCRs may be potential drug targets for many diseases, including obesity, cardiovascular disease, inflammation and cancer.
Similar articles
-
Orphan G-protein-coupled receptors: the next generation of drug targets?Br J Pharmacol. 1998 Dec;125(7):1387-92. doi: 10.1038/sj.bjp.0702238. Br J Pharmacol. 1998. PMID: 9884064 Free PMC article. Review.
-
The use of constitutively active receptors for drug discovery at the G protein-coupled receptor gene pool.Curr Opin Drug Discov Devel. 2001 Sep;4(5):548-60. Curr Opin Drug Discov Devel. 2001. PMID: 12825451 Review.
-
Alternative drug discovery approaches for orphan GPCRs.Drug Discov Today. 2008 Jan;13(1-2):52-8. doi: 10.1016/j.drudis.2007.09.011. Epub 2007 Nov 19. Drug Discov Today. 2008. PMID: 18190864 Review.
-
Structure-based identification of binding sites, native ligands and potential inhibitors for G-protein coupled receptors.Proteins. 2003 May 15;51(3):423-33. doi: 10.1002/prot.10362. Proteins. 2003. PMID: 12696053
-
Bioinformatics-based discovery and identification of new biologically active peptides for GPCR deorphanization.J Pept Sci. 2007 Sep;13(9):568-74. doi: 10.1002/psc.898. J Pept Sci. 2007. PMID: 17694568
Cited by
-
Recent advances in drug action and therapeutics: relevance of novel concepts in G-protein-coupled receptor and signal transduction pharmacology.Br J Clin Pharmacol. 2004 Apr;57(4):373-87. doi: 10.1111/j.1365-2125.2003.02046.x. Br J Clin Pharmacol. 2004. PMID: 15025734 Free PMC article. Review.
-
Overexpression of leucine-rich repeat-containing G protein-coupled receptor 5 in colorectal cancer.Cancer Sci. 2010 Jul;101(7):1731-7. doi: 10.1111/j.1349-7006.2010.01571.x. Epub 2010 Mar 24. Cancer Sci. 2010. PMID: 20384634 Free PMC article.